Avastin Prolongs Survival in Patients With Advanced Lung Cancer

A recent study regarding Avastin has come up in the medical community. This new research regarding Avastin has indicated towards the fact that Avastin has the power to dramatically improve the overall time the patients will live along with their advanced non-small cell lung cancer without witness any kind of advancement in their ailment when Avastin is given along with cisplatin or gemcitabine chemotherapy.

This outcome has been compared with the condition when the chemotherapy is given alone without Avastin added to cisplatin or gemcitabine chemotherapy. The positive results are here to alarm the whole medical community and are here to bring in Avastin in the limelight. Hopefully Avastin will be adapted as part of general chemotherapy for such cancer patients and this will bring in more positive change for these patients making them live a bit more longer than before.

Its a fact that the lung cancer alone is the cause of 1 in 3 cancer related casualties in all men all across the world while lung cancer affects and beomes cause of deaths in 1 in every 4 women having lung cancer.